Guru Ownership Trend
Guru Analysis for Phathom Pharmaceuticals, Inc. (PHAT)
Phathom Pharmaceuticals, Inc. (PHAT), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $4.64 M.
Top institutional holders include Renaissance Technologies (RenTech) and John Hussman.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $7.14 M net outflow during the quarter.
Recent activity highlights Renaissance Technologies (RenTech) who opened a new position. Conversely, John Hussman reduced exposure by 42.9%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Phathom Pharmaceuticals, Inc. (PHAT)
Major holders include Renaissance Technologies (RenTech) ($3.4 M), John Hussman ($933,240), Cliff Asness ($616,249). According to the latest reported data, 4 tracked investment managers collectively hold approximately 483,493 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $7.14 M, with 3 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 1 fully exited PHAT. The total reported sell value was $10.65 M.
Yes, 1 managers opened new positions in PHAT, and 2 increased their existing holdings. The total reported buy value was $3.52 M.